Dr. Greenfield Named Vice Chair of Academic Affairs

You are here

Dr. Jeffrey Greenfield
Dr. Jeffrey Greenfield
01-05-2018

Dr. Philip Stieg, Neurosurgeon-in-Chief of NewYork-Presbyterian and Weill Cornell Medicine and director of the Weill Cornell Medicine Brain and Spine Center, has appointed Dr. Jeffrey Greenfield as Vice Chair for Academic Affairs in the Department of Neurological Surgery. In his new role, Dr. Greenfield will oversee and manage all of the department's diverse educational programs, with particular focus on the academic achievements of our medical students, neurosurgical residents, and junior faculty.

This newly created position reflects the importance the department places on both academic success and the mentoring of a new generation of neuroscientists. As Vice Chair for Academic Affairs, Dr. Greenfield will ensure the quality of all educational programs and their compliance with regulatory requirements as well as manage the administrative needs, policies, and procedures of these programs. He will advise Dr. Stieg on priorities, management, and support for educational programs across the department and will provide metrics on all departmental CME activities.

Dr. Greenfield graduated from Amherst College magna cum laude in neuroscience before receiving his M.D. and Ph.D. degrees from the Weill Medical College of Cornell University. Following completion of his neurosurgical residency and chief residency at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, Dr. Greenfield received further training in surgical treatment of brain tumors, epilepsy, spinal dysraphism, complex spinal column injury, spinal cord tumors, and fetal surgery for myelomeningocoele at The Children’s Hospital of Philadelphia. In his position on the Weill Cornell Medicine pediatric neurosurgery team, Dr. Greenfield specializes in the treatment of Chiari malformation and is the director of the Chiari CARE program. He is also the co-director of the Children's Brain Tumor Project, where he leads a research team searching for new treatments for rare and inoperable pediatric brain tumors.

More about Dr. Greenfield